Skip to content
value.today

Cirrus Therapeutics, Inc.

Total raised
$7 M
1 round on record
Latest round
$7 M
Aug 2025
First round on record
Aug 2025
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cirrus Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Aug 2025$7 MNo. 1$2 to $10 million

Cirrus Therapeutics, Inc.: Raise no. 1, Aug 2025

Investors in this round

8 investors had bought by the notice of Aug 19, 2025: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$7 M of $16 M offered; $9 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
not stated
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Ying Kai Chan · Executive Officer, Director, Promoter
  • Alexandra Cantley · Director
  • Andrew Dick · Director, Promoter
  • Khoo Shih · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ying Kai Chan, President. Newest notice filed Aug 19, 2025. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Aug 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cirrus Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cirrus Therapeutics, Inc.
NameRoleNamed in
Ying Kai ChanExecutive officerAug 2025
Alexandra CantleyDirectorAug 2025
Andrew DickDirectorAug 2025
Khoo ShihDirectorAug 2025
Ying Kai ChanDirectorAug 2025
Andrew DickPromoterAug 2025
Ying Kai ChanPromoterAug 2025